|
Study
|
Number of patients
|
Treatment outcome (n. %)
|
|---|
| |
Included
|
Drop out*
|
Analysed
|
ACPR
|
LTF
|
LPF
|
LCF
|
|---|
|
AL2002†
|
55
|
10(4)
|
45
|
32(71.1)
|
13(28.9)
|
2(4.4)
|
11(24.5)
|
|
AL2003†
|
80
|
6(3)
|
74
|
64(86.5)
|
10(13.5)
|
6(8.1)
|
4(5.4)
|
|
AM2003‡
|
55
|
3(0)
|
52
|
48(92.3)
|
4(7.7)
|
3(5.7)
|
1(2)
|
|
AM2004‡
|
85
|
4(1)
|
81
|
75(92.6)
|
6(7.4)
|
0(0)
|
6(7.4)
|
- ACPR. Adequate Clinical and Parasitological Response; LTF. Late Treatment Failure;
- LCF. Late Clinical Failure; LPF. Late Parasitological Failure; LTF = LCF + LPF.
- *Number between parenthesis indicates the number Plasmodium vivax infections
- †Artemether 20 mg/kg and lumefantrine 120 mg/kg
- ‡Artesunate 12 mg/kg and mefloquine 25 mg/kg
